• hovercat@lemmy.blahaj.zone
    link
    fedilink
    English
    arrow-up
    2
    ·
    1 day ago

    Not only that, but targeting the ~20% of the population that’s post-menopausal cis women with all the benefits of HRT would be a WAY bigger market than the 1-5% of the population that might be trans. If it was about making money on HRT, they’re certainly not going for a very large market.

    Not only that, but wouldn’t Big Pharma™ be lobbying heavily against all the anti-trans healthcare bills? Seems like they’re doing a pretty awful job of maintaining their market.